We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Everpure Jumps 34% in a Year: Should Investors Bet on the Stock?
Read MoreHide Full Article
Key Takeaways
Everpure shares jumped 33.9% in a year, beating the industry's 10.4% return.
Everpure's Q1'27 subscription revenues rose 17%, with RPO up 41% y/y.
Everpure trades at 28.58x forward P/E, backed by 53.2% ROE and rising EPS estimates.
Everpure (P - Free Report) stock has gained 33.9%, outperforming the industry’s 10.4% return and the Zacks S&P 500 Composite's 27.6% rise.
Over the past year, the company has outpaced its close competitors, Xylem (XYL - Free Report) and Danaher (DHR - Free Report) . Xylem's shares have plunged 13.6% and Danaher's share price has decreased 8.8%.
1-Year Share Price Performance
Image Source: Zacks Investment Research
Even over the past three months, Everpure's share price has increased 20.8%, while Danaher and Xylem have declined 5.8% and 10.4%, respectively.
Considering this impressive rally, let us analyze further to determine whether investors should add Everpure to their portfolios.
During the first quarter of fiscal 2027, Everpure registered 17% year-over-year growth in its subscription revenues. On a similar note, subscription annual recurring revenues grew 19% year over year, with remaining performance obligation registering a 41% jump. It is a clear double green light since it indicates that the company expects guaranteed income right now, as well as secured a pipeline of income for the future. Therefore, the company’s subscription momentum highlights a structural pivot that can draw in highly predictable and recurring revenue streams.
Long-term investors might consider this shift highly beneficial. It replaces dynamic sales with stable recurring cash flows, which protects Everpure’s financial health during economic setbacks. High revenue visibility reduces investment risks, optimizes capital efficiency and fuels enterprise valuation.
Everpure Trades Higher Than Industry: A Deserved Premium
The P stock is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 28.58X and holds a P/E-to-growth (PEG) ratio of 1.48. While traditional metrics flag the stock as overvalued relative to the industry’s P/E multiple of 22.31X and PEG ratio of 1.15, the premium is fully justified when we consider the lofty 53.2% return on equity Everpure delivers to its shareholders, which exceeds the industry’s 12.2%.
Image Source: Zacks Investment Research
The company does not pay out any dividends, retaining 100% of its net income. Hence, reinvesting every dollar of earnings at a 53.2% internal rate of return fuels the company’s growth engine that allows it to move ahead of its peers easily.
Considering the P/E and PEG ratios, we find that the earnings growth rate of the company and the industry is close to 19.3%. While the expected growth rate is the same for Everpure and the industry, the company needs a mere fraction of its CapEx to hit that target, which will free up a hefty cash flow.
The capital-light scalability of Everpure’s business serves as an economic moat, providing a strong margin of safety during market volatility and superior earnings quality. Therefore, paying a substantial premium for Everpure’s stock is a rational trade-off to invest in a business that raises shareholder value at a faster pace.
P’s Bright Top & Bottom-Line Prospects
The Zacks Consensus Estimate for fiscal 2027 revenues is pegged at $4.5 billion, suggesting 22.7% growth from the year-ago quarter’s actual. For fiscal 2028, it is anticipated to gain 15% year over year. For earnings, the consensus estimate for fiscal 2027 is pegged at $2.46 per share, suggesting a 24.9% rise from the year-ago quarter’s actual. For fiscal 2028, it is expected to jump 26.6%.
Image Source: Zacks Investment Research
Over the past 30 days, two EPS estimates for fiscal 2027 and 2028 have been revised upward with no downward adjustments, highlighting optimistic sentiments among analysts. In the same period, the Zacks Consensus Estimate for fiscal 2027 and 2028 earnings per share moved up 1.3% and 1.7%, respectively.
Everpure: Initiate an Immediate Buy
The P stock is a compelling buy due to its financial health, shift to recurring revenues and solid capital returns. Double-digit growth in subscription revenues, combined with metrics indicating certainty in future revenues, should raise top-line visibility for investors that aids them in ascertaining profitability.
Despite trading at a premium, Everpure’s valuation is completely justified due to its strong capital return, dramatically outpacing the industry figure. The company can easily reinvest all of its earnings at an elite rate, providing a bedrock for the scalability of the company’s capital-light model.
A strong top and bottom-line outlook, coupled with optimistic analyst sentiment, is a major green flag for investors as it solidifies Everpure’s growth trajectory. A mix of economic moat, high earnings quality and shareholder value creation positions Everpure as a premium stock that investors should find worthwhile adding to their portfolio.
View the Zacks #1 Rank List
Image: Bigstock
Everpure Jumps 34% in a Year: Should Investors Bet on the Stock?
Key Takeaways
Everpure (P - Free Report) stock has gained 33.9%, outperforming the industry’s 10.4% return and the Zacks S&P 500 Composite's 27.6% rise.
Over the past year, the company has outpaced its close competitors, Xylem (XYL - Free Report) and Danaher (DHR - Free Report) . Xylem's shares have plunged 13.6% and Danaher's share price has decreased 8.8%.
1-Year Share Price Performance
Even over the past three months, Everpure's share price has increased 20.8%, while Danaher and Xylem have declined 5.8% and 10.4%, respectively.
Considering this impressive rally, let us analyze further to determine whether investors should add Everpure to their portfolios.
P’s Subscription Momentum Raises Future Revenue Visibility
During the first quarter of fiscal 2027, Everpure registered 17% year-over-year growth in its subscription revenues. On a similar note, subscription annual recurring revenues grew 19% year over year, with remaining performance obligation registering a 41% jump. It is a clear double green light since it indicates that the company expects guaranteed income right now, as well as secured a pipeline of income for the future. Therefore, the company’s subscription momentum highlights a structural pivot that can draw in highly predictable and recurring revenue streams.
Long-term investors might consider this shift highly beneficial. It replaces dynamic sales with stable recurring cash flows, which protects Everpure’s financial health during economic setbacks. High revenue visibility reduces investment risks, optimizes capital efficiency and fuels enterprise valuation.
Everpure Trades Higher Than Industry: A Deserved Premium
The P stock is currently trading at a forward 12-month price-to-earnings (P/E) multiple of 28.58X and holds a P/E-to-growth (PEG) ratio of 1.48. While traditional metrics flag the stock as overvalued relative to the industry’s P/E multiple of 22.31X and PEG ratio of 1.15, the premium is fully justified when we consider the lofty 53.2% return on equity Everpure delivers to its shareholders, which exceeds the industry’s 12.2%.
The company does not pay out any dividends, retaining 100% of its net income. Hence, reinvesting every dollar of earnings at a 53.2% internal rate of return fuels the company’s growth engine that allows it to move ahead of its peers easily.
Considering the P/E and PEG ratios, we find that the earnings growth rate of the company and the industry is close to 19.3%. While the expected growth rate is the same for Everpure and the industry, the company needs a mere fraction of its CapEx to hit that target, which will free up a hefty cash flow.
The capital-light scalability of Everpure’s business serves as an economic moat, providing a strong margin of safety during market volatility and superior earnings quality. Therefore, paying a substantial premium for Everpure’s stock is a rational trade-off to invest in a business that raises shareholder value at a faster pace.
P’s Bright Top & Bottom-Line Prospects
The Zacks Consensus Estimate for fiscal 2027 revenues is pegged at $4.5 billion, suggesting 22.7% growth from the year-ago quarter’s actual. For fiscal 2028, it is anticipated to gain 15% year over year. For earnings, the consensus estimate for fiscal 2027 is pegged at $2.46 per share, suggesting a 24.9% rise from the year-ago quarter’s actual. For fiscal 2028, it is expected to jump 26.6%.
Over the past 30 days, two EPS estimates for fiscal 2027 and 2028 have been revised upward with no downward adjustments, highlighting optimistic sentiments among analysts. In the same period, the Zacks Consensus Estimate for fiscal 2027 and 2028 earnings per share moved up 1.3% and 1.7%, respectively.
Everpure: Initiate an Immediate Buy
The P stock is a compelling buy due to its financial health, shift to recurring revenues and solid capital returns. Double-digit growth in subscription revenues, combined with metrics indicating certainty in future revenues, should raise top-line visibility for investors that aids them in ascertaining profitability.
Despite trading at a premium, Everpure’s valuation is completely justified due to its strong capital return, dramatically outpacing the industry figure. The company can easily reinvest all of its earnings at an elite rate, providing a bedrock for the scalability of the company’s capital-light model.
A strong top and bottom-line outlook, coupled with optimistic analyst sentiment, is a major green flag for investors as it solidifies Everpure’s growth trajectory. A mix of economic moat, high earnings quality and shareholder value creation positions Everpure as a premium stock that investors should find worthwhile adding to their portfolio.
Everpure has a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.